Similar Articles
1621 Diabetes mellitus and metformin in hepatocellular carcinoma
1622 Hepatocellular carcinoma: Will novel targeted drugs really impact the next future?
1623 Alpha-fetoprotein-targeted reporter gene expression imaging in hepatocellular carcinoma
1624 Serum metabolome profiles characterized by patients with hepatocellular carcinoma associated with hepatitis B and C
1625 Immunohistochemistry panel segregates molecular types of hepatocellular carcinoma in Brazilian autopsy cases
1626 Prognostic value of inflammation-based markers in patients with pancreatic cancer administered gemcitabine and erlotinib
1627 Pancreatic cancer stem cell markers and exosomes - the incentive push
1628 Preliminary study on overproduction of reactive oxygen species by neutrophils in diabetes mellitus
1629 Liquid biopsy in patients with pancreatic cancer: Circulating tumor cells and cell-free nucleic acids
1630 Clinical analysis of patients with hepatocellular carcinoma recurrence after living-donor liver transplantation
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA